Injective (INJ) up 13% post-INJ 3.0 governance proposal (IIP-392) approval The IIP-392 proposal cuts INJ’s token supply, boosting its value Injective’s rise is further supported by the growing ...

Injective (INJ) surged 30% in a week, supported by bullish momentum and an overbought RSI at 80.6. A potential golden cross could drive INJ to resistance levels at $26.5, $29.4, and $35.2, marking a ...

The Injective 3.0 Upgrade has passed a proposal from the community. The new upgrade will help adjust INJ tokenomics using staking balancing algorithms. The price of INJ is reacting positively to ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

The recent announcement of INJ 3.0 focuses on significantly decreasing the token supply. On-chain data further boosts the bullish outlook as INJ’s Total Value Locked and Open Interest are rising.

This page will be updated throughout the offseason, with all the latest Marlins signings, news and transactions. Dec. 29: Marlins acquire 1B Matt Mervis and cash for UTIL Vidal Bruján Mervis, who once ...